Life Insurance Corporation Of India

NSE: LICI · Financial Services · Lot size: 700

Life Insurance Corporation Of India Open Interest & PCR Analysis

400Updated 5 Jun 2026, 03:30 pm IST
PCR
0.70
Bearish signal
Max Pain
410
Spot below by ₹10
Total CE OI
17.22M
Call writers
Total PE OI
12.02M
Put writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish

Data as of 2026-06-05

Frequently Asked Questions

What is Life Insurance Corporation Of India PCR (Put-Call Ratio) today?
Life Insurance Corporation Of India's current PCR is 0.70. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Life Insurance Corporation Of India's PCR of 0.70 indicates bearish sentiment.
What is Life Insurance Corporation Of India OI buildup type today?
Life Insurance Corporation Of India is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Life Insurance Corporation Of India?
Life Insurance Corporation Of India has total CE (call) OI of 17216500 contracts and total PE (put) OI of 12021100 contracts for the nearest expiry. The PCR is 0.70.
How is open interest analysis useful for Life Insurance Corporation Of India trading?
OI analysis for Life Insurance Corporation Of India helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Life Insurance Corporation Of India?
Life Insurance Corporation Of India's max pain is ₹410 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.